Published On: Thu, Mar 29th, 2018

Edge Therapeutics Inc. (EDGE) Tanked After Phase 3 Study Scrapped

Edge Inc. (EDGE) announced Wednesday morning that it will discontinue its 3 of EG-1962 in adults with aneurysmal subarachnoid hemorrhage based on the recommendation of the independent Data Monitoring Committee.

About the Author

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>